Back to results
US 2022/0110987 A1Published application
Multiple viral antigen covid vaccine and therapeutic
AssigneeHeba Hamida
InventorHeba Hamida
Life of this patent
Estimating the term…
Abstract
A composition for treating or preventing COVID-19 infection is described. The composition includes attenuated Measles virus particles; attenuated Mumps virus particles; attenuated Rubella II virus particles; scorpion antivenom; and a pharmaceutically acceptable carrier. The composition can be used in a method of treating COVID-19 infection in a subject, and can also be used in a method of vaccinating a subject to decrease the risk or severity of infection by COVID-19.
Claims22
A composition for treating or preventing COVID-19 infection, comprising:
- attenuated Measles virus particles;
- attenuated Mumps virus particles;
- attenuated Rubella II virus particles;
- scorpion antivenom;
- and
- a pharmaceutically acceptable carrier.
3 more elements
Dependencies are inferred from the claim text.